Recent publications on Cancer

Brown MC, Snidarich M, Budak JZ, Murphy N, Giustini N, Romine PE, Weiner BJ, Caverly T, Crothers K, Triplette M. Adaptation of a tailored lung cancer screening decision aid for people with HIV. CHEST Pulm. 2024;2(3):100044. doi: 10.1016/j.chpulm.2024.100044. Epub 2024 Feb 19.  PubMed

Ike B, Johnson A, Meza R, Cole A. Integrating causal pathway diagrams into practice facilitation to address colorectal cancer screening disparities in primary care.  BMC Health Serv Res. 2024;24(1):1007. doi: 10.1186/s12913-024-11471-5.  PubMed

Stout NK, Miglioretti DL, Su YR, Lee CI, Abraham L, Alagoz O, de Koning HJ, Hampton JM, Henderson L, Lowry KP, Mandelblatt JS, Onega T, Schechter CB, Sprague BL, Stein S, Trentham-Dietz A, van Ravesteyn NT, Wernli KJ, Kerlikowske K, Tosteson ANA. Breast cancer screening using mammography, digital breast tomosynthesis, and magnetic resonance imaging by breast density. JAMA Intern Med. 2024 Aug 26:e244224. doi: 10.1001/jamainternmed.2024.4224. PubMed

Navarro SL, Williamson BD, Huang Y, Nagana Gowda GA, Raftery D, Tinker LF, Zheng C, Beresford SAA, Purcell H, Djukovic D, Gu H, Strickler HD, Tabung FK, Prentice RL, Neuhouser ML, Lampe JW. Metabolite predictors of breast and colorectal cancer risk in the women's health initiative. Metabolites. 2024;14(8):463. doi: 10.3390/metabo14080463.  PubMed

Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski RP, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Aiello Bowles EJ, Kushi LH, Kantor ED. The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system. Breast Cancer Res Treat. 2024 Aug 16. doi: 10.1007/s10549-024-07433-4. [Epub ahead of print]. PubMed

Aiello Bowles EJ, Ramin C, Vo JB, Feigelson HS, Gander JC, Veiga LHS, Bodelon C, Curtis RE, Brandt C, Berrington de Gonzalez A, Gierach GL. Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ from 2001-2018. Breast Cancer Res Treat. 2024 Aug 16. doi: 10.1007/s10549-024-07453-0. Online ahead of print. PubMed

Issaka RB, Ibekwe LN, Todd KW, Burnett-Hartman AN, Clark CR, Del Vecchio NJ, Kamineni A, Neslund-Dudas C, Chubak J, Corley DA, Haas JS, Honda SA, Li CI, Winer RL, Pruitt SL. Association between racial residential segregation and screening uptake for colorectal and cervical cancer among Black and White patients in five US health care systems. Cancer. 2024 Aug 9. doi: 10.1002/cncr.35514. [Epub ahead of print]. PubMed

Lange JM, Gard CC, O'Meara ES, Miglioretti DL, Etzioni R. Breast density and risk of breast cancer: Masking and detection bias. Am J Epidemiol. 2024 Aug 3:kwae245. doi: 10.1093/aje/kwae245. [Epub ahead of print]. PubMed

Sprague BL, Ichikawa L, Eavey J, Lowry KP, Rauscher GH, O'Meara ES, Miglioretti DL, Lee JM, Stout NK, Herschorn SD, Perry H, Weaver DL, Kerlikowske K. Performance of supplemental US screening in women with dense breasts and varying breast cancer risk: Results from the Breast Cancer Surveillance Consortium. Radiology. 2024 Aug;312(2):e232380. doi: 10.1148/radiol.232380. PubMed

Briggs ES, Thomas RM, Frost MC, Fletcher OV, Crothers K, Chalal CK, Shahrir SF, McClure JB, Catz SL, Williams EC. "I thought cancer was a tobacco issue": Perspectives of veterans with and without HIV on cancer and other health risks associated with alcohol and tobacco/nicotine use. AIDS Behav. 2024;28(8):2607-2618. doi: 10.1007/s10461-024-04363-6. Epub 2024 Jun 13. PubMed

Murphy NR, Crothers K, Snidarich M, Budak JZ, Brown MC, Weiner BJ, Giustini N, Caverly T, Durette K, DeCell K, Triplette M. A tailored decision aid improves understanding of lung cancer screening in people with HIV. Chest. 2024 Jul 29:S0012-3692(24)04876-1. doi: 10.1016/j.chest.2024.07.147. [Epub ahead of print]. PubMed

Bhimani J, O’Connell K, Persaud S, Blinder V, Burganowski R, Ergas IJ, Foley M, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Bowles EJA, Kushi LH, Kantor ED. Patient characteristics associated with intended non-guideline chemotherapy in women with stage I-IIIA breast cancer. Cancer Epidemiol Biomarkers Prev. 2024 Jul 25. doi: 10.1158/1055-9965.EPI-24-0360. Online ahead of print. PubMed

Dang TH, Rieu-Werden ML, Kobrin SC, Tiro JA, Werner C, Lykken JM, Chubak J, Atlas SJ, Higashi RT, Lee SC, Haas JS, Skinner CS, Silver MI, Feldman S. Association between clinician confidence and making guideline-recommended decisions in the management of abnormal cervical cancer screening results. J Gen Intern Med. 2024 Jul 25. doi: 10.1007/s11606-024-08943-z. [Epub ahead of print]. PubMed

White LL, Sawyer JK, Zepp JM, Prado YK, Reyes AA, Maiyani M, Shuster E, Zucker R, Henrikson NB, Rope AF, Weinmann S, Feigelson HS, Ezzell Hunter J. Genetic testing uptake among ovarian cancer survivors in the Genetic Risk Analysis in Ovarian Cancer (GRACE) study. Cancers (Basel). 2024;16(14):2563. doi: 10.3390/cancers16142563.  PubMed

Bhimani J, O’Connell K, Persaud S, Blinder V, Burganowski R, Ergas IJ, Foley M, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Bowles EJA, Kushi LH, Kantor ED. Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer. Int J Cancer. 2024 Jul 6. doi: 10.1002/ijc.35053. Online ahead of print. PubMed

Lee JM, Ichikawa LE, Kerlikowske K, Buist DSM, Lee CI, Sprague BL, Henderson LM, Onega T, Wernli KJ, Lowry KP, Stout NK, Tosteson ANA, Miglioretti DL. Relative timing of mammography and MRI for breast cancer screening: Impact on performance evaluation. J Am Coll Radiol. 2024 Jul 3:S1546-1440(24)00597-0. doi: 10.1016/j.jacr.2024.06.020. Online ahead of print. PubMed

Boratyn VM, Pocobelli G, Atlas SJ, Clark CR, Feldman S, Kruse G, Marie McCarthy A, Rieu-Werden M, Silver MI, Santini NO, Tiro JA, Haas JS. Clinician-perceived barriers to cervical cancer screening before and during the COVID-19 pandemic at three US healthcare systems.  Prev Med Rep. 2024 Jun 1;43:102783. doi: 10.1016/j.pmedr.2024.102783. eCollection 2024. PubMed

Petrik AF, Rivelli JS, Firemark AJ, Johnson CA, Locher BW, Gille S, Najarian MJ, Varga AM, Schneider JL, Green B, Winer RL. A qualitative assessment of the acceptability of human papillomavirus self-sampling and informational materials among diverse populations.  Cancer Med. 2024;13(14):e70033. doi: 10.1002/cam4.70033.  PubMed

Bhimani J, O'Connell K, Ergas IJ, Foley M, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Rivera DR, Roh JM, Tabatabai S, Valice E, Bowles EJA, Bandera EV, Kushi LH, Kantor ED. Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019.  Breast Cancer Res. 2024;26(1):101. doi: 10.1186/s13058-024-01822-9.  PubMed

Hahn EE, Munoz-Plaza CE, Jensen CD, Ghai NR, Pak K, Amundsen BI, Contreras R, Cannizzaro N, Chubak J, Green BB, Skinner CS, Halm EA, Schottinger JE, Levin TR. Patterns of care following a positive fecal blood test for colorectal cancer: A mixed methods study. J Gen Intern Med. 2024 May 21. doi: 10.1007/s11606-024-08764-0. [Epub ahead of print]. PubMed